You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《亚洲股市》日经及韩股升幅扩至1.1%至1.4% 港股高开0.6%
阿思达克 02-01 09:29
药厂强生研发的新冠疫苗於全球试验中有效率仅66%,加上对冲基金与散户投资者之间对峙未有平息迹象,市场对高度投机交易将加剧大市波动忧虑升温,美股三大指数继上周五急吐约2%後,期货全面续跌0.2%-0.5%。不过,亚太区股市今早个别发展,受惠圆汇转弱日经及经济数据理想韩股分别升1.1%及1.4%,报27,956及3,017。

本港去年第四季GDP初值按年萎缩续收窄至3%,逊於市场预期萎缩2.1%,且已连续六季萎缩;季调後按季仅续增0.2%,也逊於市场预期增长0.8%及前值恢复增长2.8%。累计2020年全年,本港GDP初值萎缩至6.1%略逊预期,且为1961年有纪录以来最差。不过,港股继上周累吐1,164点或近4%後,今早扭四连跌,在小米(01810.HK)、创科(00669.HK)、腾讯(00700.HK)、申洲(02313.HK)及美团(03690.HK)高开1.9%-3.7%支持,恒指高开174点或0.6%报28,457。

沪指及深成继上周分别累吐3.4%及5.2%後,前值今早延续过去两连跌势,低开近0.2%报3,477,後者扭两连跌,高开0.1%报14,841。

星股连跌第三天,报2877,跌0.9%。新西兰股市回落0.6%报13,042。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account